Skip to content

Clinical trials

Phase 2/3 Leukemia, Myeloid, Acute trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 2/3 Country / region: Spain Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20151
20201
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie1
AstraZeneca1
Gamida Cell -Teva Joint Venture Ltd.1
Janssen Research & Development, LLC1
Moleculin Biotech, Inc.1
Taiho Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute6
Myelodysplastic Syndromes2
Anemia, Refractory, with Excess of Blasts1
Hematologic Diseases1
Hematologic Neoplasms1
Hodgkin Disease1
Leukemia1
Leukemia, Lymphoid1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
Leukemia, Myelomonocytic, Chronic1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.